Evidence-based medicine: We ought to practise it, but we still do not know why

Journal of Evaluation in Clinical Practice

Volumn 18, Issue 5, 2012, Pages 1111-1112

  Gupta, Mona ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

clinical decision making; critical appraisal; data; evidence based medicine; value free; value laden

Indexed keywords

EVIDENCE BASED MEDICINE; HEALTH STATUS; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL DECISION MAKING; MEDICAL RESEARCH; NOTE; PRIORITY JOURNAL;

DECISION MAKING; ETHICS, CLINICAL; EVIDENCE-BASED MEDICINE; HUMANS; INFORMED CONSENT; PATIENT PARTICIPATION;

EID: 84866654348     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2012.01928.x     Document Type: Note

References (5)

1. Straus, S. E., (2011) Evidence-Based Medicine: How to Practice and Teach It. Edinburgh: Elsevier Churchill Livingstone.
2. Guyatt, G., &, Rennie, D., (2002) User's Guide to the Medical Literature. 1st edn. Chicago, IL: AMA Press.
3. Perlis, R. H., Perlis, C. S., Wu, Y., Hwang, C., Joseph, M., &, Nierenberg, A. A., (2005) Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. The American Journal of Psychiatry, 162 (10), 1957-1960.
4. Schott, G., Pachl, H., Limbach, U., Gundert-Remy, U., Ludwig, W.-D., &, Lieb, K., (2010) The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials. Deutsches Îrzteblatt International, 107 (16), 279-285.
5. Schott, G., Pachl, H., Limbach, U., Gundert-Remy, U., Lieb, K., &, Ludwig, W.-D., (2010) The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication. Deutsches Îrzteblatt International, 107 (17), 295-301.